Published in Am J Transplant on August 04, 2006
The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation (2013) 1.86
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
The effect of race and income on living kidney donation in the United States. J Am Soc Nephrol (2013) 1.72
Attitudes toward strategies to increase organ donation: views of the general public and health professionals. Clin J Am Soc Nephrol (2012) 1.66
Health insurance status of US living kidney donors. Clin J Am Soc Nephrol (2010) 1.16
Reducing the financial disincentives to living kidney donation: will compensation help the way it is supposed to? Nat Clin Pract Nephrol (2007) 0.99
Economic consequences incurred by living kidney donors: a Canadian multi-center prospective study. Am J Transplant (2014) 0.92
The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial. BMC Nephrol (2012) 0.90
The association of state and national legislation with living kidney donation rates in the United States: a national study. Am J Transplant (2008) 0.89
Should we pay donors to increase the supply of organs for transplantation? Yes. BMJ (2008) 0.89
The cost-effectiveness of using payment to increase living donor kidneys for transplantation. Clin J Am Soc Nephrol (2013) 0.83
The price is wrong: the moral cost of living donor inducements. Am J Transplant (2006) 0.75
Reimbursing living organ donors for incurred costs. Am J Transplant (2007) 0.75
Living organ donation: an ethical evolution or evolution of ethics? Int J Organ Transplant Med (2010) 0.75
Reciprocating living kidney donor generosity: tax credits, health insurance and an outcomes registry. Clin Kidney J (2015) 0.75
Health Insurance Trends in United States Living Kidney Donors (2004 to 2015). Am J Transplant (2016) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Nondirected donation of kidneys from living donors. N Engl J Med (2000) 3.87
The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant (2007) 3.12
The effect of race on access and outcome in transplantation. N Engl J Med (1991) 2.98
A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant (2010) 2.69
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
MELD Exceptions and Rates of Waiting List Outcomes. Am J Transplant (2011) 2.47
Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant (2013) 2.46
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32
Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry (1990) 2.13
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant (2011) 2.10
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant (2012) 1.90
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant (2007) 1.88
Disparities in the utilization of live donor renal transplantation. Am J Transplant (2009) 1.87
Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant (2009) 1.83
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant (2015) 1.76
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation (2000) 1.72
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation (1999) 1.62
Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis (1998) 1.62
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant (2014) 1.59
Helical CT angiography for examination of living renal donors. AJR Am J Roentgenol (1997) 1.58
Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant (2001) 1.56
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant (2006) 1.52
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Obesity and outcome following renal transplantation. Am J Transplant (2006) 1.46
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1996) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant (2007) 1.37
Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate. Medicine (Baltimore) (1978) 1.34
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Liver transplantation today. Ann Intern Med (1986) 1.34
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
Aluminium toxicity in rats. Lancet (1972) 1.23
Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage. Am J Transplant (2008) 1.22
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant (2002) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Cataracts of chronic renal failure. Lancet (1972) 1.17
Pediatric renal transplants--results with sequential immunosuppression. Transplantation (1992) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased, and transplanted human kidneys. Am J Pathol (1978) 1.14
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 1.13
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation (1999) 1.11
Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet (1975) 1.09
The sensitivities and response times of ventilatory assistors. Anesthesiology (1971) 1.08
Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. Am J Med (1976) 1.08
OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant (2014) 1.08
The high cost of delayed graft function in cadaveric renal transplantation. Transplantation (1991) 1.08
Soda lime adsorption of isoflurane and enflurane. Anesthesiology (1985) 1.07
Amyloid goitre in familial Mediterranean fever. Clin Endocrinol (Oxf) (1979) 1.07
OPTN/SRTR 2012 Annual Data Report: lung. Am J Transplant (2014) 1.07
Short-term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery (1976) 1.07
Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation (1992) 1.05
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc (1979) 1.04
Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation (1994) 1.04
Renal transplantation in infants. Ann Surg (1990) 1.04
Use of cardioprotective medications in kidney transplant recipients. Am J Transplant (2009) 1.03
Chain transplantation: initial experience of a large multicenter program. Am J Transplant (2012) 1.02
Economic impact of delayed graft function. Transplant Proc (1991) 1.02
The dispersed pancreas: transplantation without islet purification in totally pancreatectomized dogs. Diabetologia (1977) 1.01
A new device for CPAP by nasal route. Crit Care Med (1975) 1.01
Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation (1993) 1.01
Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation (1996) 1.01
The interaction of anesthetic agents and adrenergic drugs to produce cardiac arrhythmias. Anesthesiology (1968) 1.00
Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc (1990) 1.00
Letter: Increased serum creatinine resulting from hyperglycemia, mimicking transplant rejection. Ann Intern Med (1975) 1.00
Laparoscopic drainage of lymphoceles after kidney transplantation: indications and limitations. Surgery (1995) 1.00